» Authors » Davide Maspero

Davide Maspero

Explore the profile of Davide Maspero including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 244
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ascolani G, Angaroni F, Maspero D, Craighero F, Bhavesh N, Piazza R, et al.
BMC Bioinformatics . 2023 Mar; 24(1):99. PMID: 36932333
Background: Longitudinal single-cell sequencing experiments of patient-derived models are increasingly employed to investigate cancer evolution. In this context, robust computational methods are needed to properly exploit the mutational profiles of...
2.
Mella L, Lal A, Angaroni F, Maspero D, Piazza R, Sidow A, et al.
STAR Protoc . 2022 Jul; 3(3):101513. PMID: 35779264
We outline the features of the R package SparseSignatures and its application to determine the signatures contributing to mutation profiles of tumor samples. We describe installation details and illustrate a...
3.
Ramazzotti D, Maspero D, Angaroni F, Spinelli S, Antoniotti M, Piazza R, et al.
iScience . 2022 Jun; 25(6):104487. PMID: 35677393
A key task of genomic surveillance of infectious viral diseases lies in the early detection of dangerous variants. Unexpected help to this end is provided by the analysis of deep...
4.
Ramazzotti D, Angaroni F, Maspero D, Ascolani G, Castiglioni I, Piazza R, et al.
Nat Commun . 2022 May; 13(1):2718. PMID: 35551450
No abstract available.
5.
Calabretta E, Guidetti A, Ricci F, di Trani M, Monfrini C, Magagnoli M, et al.
Br J Haematol . 2022 Apr; 198(1):82-92. PMID: 35468225
Checkpoint inhibitors (CPIs) are routinely employed in relapsed/refractory classical Hodgkin lymphoma. Nonetheless, persistent long-term responses are uncommon, and one-third of patients are refractory. Several reports have suggested that treatment with...
6.
Ramazzotti D, Angaroni F, Maspero D, Mauri M, DAliberti D, Fontana D, et al.
Virus Evol . 2022 Apr; 8(1):veac026. PMID: 35371557
Many large national and transnational studies have been dedicated to the analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) genome, most of which focused on missense and nonsense mutations....
7.
Machicao J, Craighero F, Maspero D, Angaroni F, Damiani C, Graudenzi A, et al.
Curr Genomics . 2021 Jul; 22(2):88-97. PMID: 34220296
Background: The increasing availability of omics data collected from patients affected by severe pathologies, such as cancer, is fostering the development of data science methods for their analysis. Introduction: The...
8.
Ramazzotti D, Angaroni F, Maspero D, Gambacorti-Passerini C, Antoniotti M, Graudenzi A, et al.
Patterns (N Y) . 2021 Mar; 2(3):100212. PMID: 33728416
We introduce VERSO, a two-step framework for the characterization of viral evolution from sequencing data of viral genomes, which is an improvement on phylogenomic approaches for consensus sequences. VERSO exploits...
9.
Graudenzi A, Maspero D, Angaroni F, Piazza R, Ramazzotti D
iScience . 2021 Feb; 24(2):102116. PMID: 33532709
To dissect the mechanisms underlying the inflation of variants in the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) genome, we present a large-scale analysis of intra-host genomic diversity, which reveals...
10.
Patruno L, Maspero D, Craighero F, Angaroni F, Antoniotti M, Graudenzi A
Brief Bioinform . 2020 Oct; 22(4). PMID: 33003202
Motivation: The advancements of single-cell sequencing methods have paved the way for the characterization of cellular states at unprecedented resolution, revolutionizing the investigation on complex biological systems. Yet, single-cell sequencing...